Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients

OBJECTIVE: Tolvaptan, a vasopressin V(2) receptor antagonist, is an oral diuretic. Patients with terminal cancer develop marked fluid retention, and oral diuretics other than tolvaptan have been used as treatments without clear therapeutic effects. Herein, we aimed to study the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuzuki, Norimasa, Usui, Masanobu, Itoh, Akihiro, Futamura, Akihiko, Imai, Kazuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fujita Medical Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923446/
https://www.ncbi.nlm.nih.gov/pubmed/36789131
http://dx.doi.org/10.20407/fmj.2021-005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923446/
https://www.ncbi.nlm.nih.gov/pubmed/36789131
http://dx.doi.org/10.20407/fmj.2021-005

Ejemplares similares